| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |